What We Know About Diet, Genes, and Dyslipidemia: Is There Potential for Translation?

Toni I Pollin1, Michael Quartuccio2

  • 1Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland ; Program in Genetics and Genomic Medicine, Department of Epidemiology & Public Health, University of Maryland School of Medicine, Baltimore, Maryland.

Current Nutrition Reports
|February 14, 2014
PubMed

Insights

Genetics influence dyslipidemia, a risk factor for coronary artery disease (CAD). Research is ongoing to link genetic variations to dietary responses for personalized CAD prevention strategies.

Area of Science:

  • Cardiovascular Science
  • Nutrigenetics
  • Medical Genetics

Background:

  • Cardiovascular disease (CVD), especially coronary artery disease (CAD), is a primary cause of mortality in the US.
  • Dyslipidemia, characterized by abnormal lipid levels (e.g., high LDL-C, triglycerides; low HDL-C), is a significant CAD risk factor.
  • Both genetic and lifestyle factors, particularly diet, influence dyslipidemia development.

Purpose of the Study:

  • To explore the genetic underpinnings of dyslipidemia.
  • To investigate how genetic differences impact lipid responses to dietary interventions.
  • To assess the potential for personalized dietary recommendations for dyslipidemia management.

Main Methods:

  • Review of recent advancements in understanding the genetic basis of dyslipidemia.
  • Analysis of existing data on genetic variations and their association with lipid profiles.
  • Examination of current dietary recommendations for monogenic lipid disorders.

Main Results:

  • Significant progress has been made in identifying genes associated with dyslipidemia.
  • Some monogenic conditions, like familial hypercholesterolemia, have established dietary guidelines.
  • Emerging associations for polygenic dyslipidemia require further investigation in large-scale dietary studies.

Conclusions:

  • Understanding genetic influences on dyslipidemia is crucial for CAD prevention.
  • Personalized dietary recommendations based on genetic profiles show promise but need more research.
  • Large dietary intervention studies incorporating genetic data are necessary for clinical translation.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.0K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
194
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.5K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K